Clinical Trials
586
Active:4
Completed:204
Trial Phases
4 Phases
Phase 2:19
Phase 3:31
Phase 4:4
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (390 trials with phase data)• Click on a phase to view related trials
Not Applicable
331 (84.9%)Phase 3
31 (7.9%)Phase 2
19 (4.9%)phase_2_3
5 (1.3%)Phase 4
4 (1.0%)Comparison of the Impact of Different Suspension Mediums on ABO Antibody Titres.
Completed
- Conditions
- Healthy Blood Donor
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 200
- Registration Number
- NCT07054372
- Locations
- 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India
Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.
Not Applicable
Not yet recruiting
- Conditions
- Decompensated Liver Cirrhosis
- Interventions
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 60
- Registration Number
- NCT07002827
- Locations
- 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India
Comparing Portal Vein Assessment by Intraoperative Doppler and Transesophageal Echocardiography
Completed
- Conditions
- Chronic Liver Disease
- First Posted Date
- 2025-04-03
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 25
- Registration Number
- NCT06909175
- Locations
- 🇮🇳
ILBS, Delhi, India
The Study of Association of Helicobacter Infections in Biliary Tract Cancers
Not yet recruiting
- Conditions
- Biliary Tract Cancer
- First Posted Date
- 2025-04-03
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 250
- Registration Number
- NCT06909188
- Locations
- 🇮🇳
ILBS, New Delhi, Delhi, India
Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.
Not Applicable
Not yet recruiting
- Conditions
- Autoimmune Hepatitis
- Interventions
- Biological: Plasma ExchangeDietary Supplement: DietDrug: Steroid
- First Posted Date
- 2025-03-04
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Institute of Liver and Biliary Sciences, India
- Target Recruit Count
- 50
- Registration Number
- NCT06855667
- Locations
- 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India
- Prev
- 1
- 2
- 3
- 4
- 5
- 56
- Next
News
No news found